Hyperconcentrated Mucus Unifies Submucosal Gland and Superficial Airway Dysfunction in Cystic Fibrosis
Takafumi Kato,Giorgia Radicioni,Micah J. Papanikolas,Georgi V. Stoychev,Matthew R. Markovetz,Kazuhiro Aoki,Mindy Porterfield,Kenichi Okuda,Selene M. Barbosa Cardenas,Rodney C. Gilmore,Cameron B. Morrison,Camille Ehre,Kimberlie A. Burns,Kristen K. White,Tara A. Brennan,Henry P. Goodell,Holly Thacker,Henry T. Loznev,Lawrence J. Forsberg,Takahide Nagase,Michael Rubinstein,Scott H. Randell,Michael Tiemeyer,David B. Hill,Mehmet Kesimer,Wanda K. O’Neal,Stephen T. Ballard,Ronit Freeman,Brian Button,Richard C. Boucher
DOI: https://doi.org/10.1101/2021.09.22.461306
2021-01-01
bioRxiv
Abstract:Cystic fibrosis (CF) is characterized by abnormal transepithelial ion transport. However, a description of CF lung disease pathophysiology unifying superficial epithelial and submucosal gland (SMG) dysfunctions has remained elusive. We hypothesized that biophysical abnormalities associated with CF mucus hyperconcentration provide a unifying mechanism. Studies of the anion secretion-inhibited pig airway CF model revealed elevated SMG mucus concentrations, osmotic pressures, and SMG mucus accumulation. Human airway studies revealed hyperconcentrated CF SMG mucus with raised osmotic pressures and cohesive forces predicted to limit SMG mucus secretion/release. Utilizing proline-rich protein 4 (PRR4) as a biomarker of SMG secretion, proteomics analyses of CF sputum revealed markedly lower PRR4 levels compared to healthy and bronchiectasis controls, consistent with a failure of CF SMGs to secrete mucus onto airway surfaces. Raised mucus osmotic/cohesive forces, reflecting mucus hyperconcentration, provide a unifying mechanism that describes disease-initiating mucus accumulation on airway surfaces and within SMGs of the CF lung.
### Competing Interest Statement
The authors have declared no competing interest.